Non-erosive Gastroesophageal Reflux Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-09-08
Clinical Trial Update: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease [Phase 3]
Phase 3 clinical trial update for JP-1366 in non-erosive gastroesophageal reflux disease; the study is currently not yet recruiting.
CLINICAL_TRIALS trial_result · 2023-01-04
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease [Phase 2]
Phase 2 trial comparing vonoprazan to placebo in symptomatic non-erosive gastroesophageal reflux disease has completed with results posted.
CLINICAL_TRIALS trial_result · 2022-11-09
Clinical Trial Update: Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease [Phase 3]
Phase 3 trial evaluating safety and efficacy of HIP1601 in non-erosive reflux disease has completed.
CLINICAL_TRIALS trial_result · 2019-08-02
Clinical Trial Update: Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD) [Phase 3]
Phase 3 trial update for TAK-438 10 mg in non-erosive gastroesophageal reflux disease has completed with results posted.
CLINICAL_TRIALS trial_result · 2019-06-25
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease [Phase 3]
Phase 3 trial evaluating the efficacy and safety of DWP14012 in patients with non-erosive gastroesophageal reflux disease; status is unknown…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2014-08-06
Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents [Phase 2]
Phase 2 trial assessing the safety and efficacy of Dexlansoprazole delayed-release capsules for symptomatic non-erosive gastroesophageal ref…
CLINICAL_TRIALS trial_result · 2012-02-10
Clinical Trial Update: Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease [Phase 3]
A Phase 3 clinical trial evaluated the efficacy and safety of sodium alginate oral suspension for non-erosive gastroesophageal reflux diseas…
CLINICAL_TRIALS trial_result · 2011-11-21
Clinical Trial Update: Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial of famotidine in non-erosive gastroesophageal reflux disease has completed.
CLINICAL_TRIALS trial_result · 2011-10-05
Clinical Trial Update: A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 trial evaluating E3810 for non-erosive gastroesophageal reflux disease using pre- and post-treatment pH monitoring was completed, …
CLINICAL_TRIALS trial_result · 2011-06-17
Clinical Trial Update: A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease [Phase 3]
A Phase 3 trial comparing the efficacy and safety of E3810 in patients with non-erosive gastroesophageal reflux disease has completed, with …